Veredus launches powerful multiplexed molecular diagnostic lab-on-chip targeting global threat of MDR-TB

Veredus Laboratories has launched VereMTBTM, a multiplexed molecular diagnostic chip capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and its mutations, as well as 9 other clinically relevant non-tubercular mycobacterium. These mutations are responsible for resistance to multiple drugs and are reinvigorating the global spread of Tuberculosis.